Nektar Therapeutics
Closed
75.04 0.79
Overview
Share price change
24h
Min
73.65
Max
74.81
Income | 4.3M -41M |
|---|---|
Sales | -730K 10M |
EPS | -1.23 |
Profit margin | -400.967 |
Employees | 63 |
EBITDA | -5.5M -42M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +91.34% upside |
Next Earnings | 5 lis 2026 |
|---|
Market Cap | -13M 2.5B |
|---|---|
Previous open | 74.25 |
Previous close | 75.04 |
Nektar Therapeutics Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Nektar Therapeutics Forecast
Price Target
By TipRanks
91.34% upside
12 Months Forecast
Average 143.43 USD 91.34%
High 192 USD
Low 65 USD
Based on 9 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$